WHOOP Secures $575 Million Series G to Fuel Global Health Operating System Expansion

Scaling Human Performance

WHOOP announced a massive $575 million Series G funding round today, bringing its total valuation to an impressive $10.1 billion. The round was led by Collaborative Fund and featured a high profile roster of investors including Abbott, Mayo Clinic, and legendary athletes like Cristiano Ronaldo and LeBron James. This capital will be used to accelerate the company's international reach and its long term vision for personalized health. The Boston based company has seen explosive growth over the past year, exiting 2025 with a $1.1 billion revenue run rate and achieving cash flow positivity. With over 2.5 million members globally, WHOOP is now generating sixty percent of its new sales outside the United States. To support this momentum, the team is hiring for more than 600 new roles across its hardware, software, and research divisions this year.

The Future of Personalized Health

WHOOP offers a unique screenless wearable that monitors physiological data like sleep, recovery, and heart rate variability 24/7. Unlike traditional devices, the platform operates on a subscription model that provides the hardware for free while focusing on deep data insights. Recent updates have introduced medical grade features such as an FDA cleared ECG and blood pressure monitoring to provide a more holistic view of longevity. Looking ahead, the company is doubling down on its partnership with Abbott to integrate diagnostics and medical devices into its ecosystem. Users can expect more advanced predictive AI models that identify early warning signs of illness before symptoms appear. This evolution aims to transform the wearable into a proactive tool for managing chronic disease and extending healthspan. As WHOOP expands into new markets like Asia and Latin America, it continues to define itself as a premium choice for elite performance. The recent viral presence of trackers on professional athletes underscores the brand's cultural dominance. This strategic positioning, combined with its strong financial footing, sets a clear path toward a potential IPO in the next twenty four months.